Symptoms

Hot Flushes: Why They Happen and What You Can Do About Them

By Hysteron4 min read
Illustration of a woman in a meeting with a heat shimmer and a desk fan, for an article on hot flushes

Hot flushes are the menopause symptom everyone has heard of, and one of the best studied. Research shows they happen because falling oestrogen changes the way the brain controls body temperature, so small shifts in heat that once went unnoticed now set off a full cooling response. Several evidence-based options exist for managing them, from everyday adjustments to medical treatment.

They have become shorthand for the whole of menopause. That helps in one way, since they are hard to dismiss, and it also flattens the picture, because menopause involves far more than flushes, as our guide to the full list of menopause symptoms shows.

Compared with some of the less visible symptoms on that list, hot flushes have a large body of research behind them, and that research gives you real choices.

What happens in your body during a hot flush?

Doctors call a hot flush a vasomotor symptom. Women typically describe a sudden, intense wave of heat that spreads from the chest and neck to the face, often with visible flushing and sweating. A chill tends to follow as the body overcorrects. Each episode usually lasts two to four minutes, although experiences vary a great deal from one woman to the next.

The cause lies in the hypothalamus, the part of your brain that acts as your internal thermostat. Oestrogen helps maintain what scientists call the thermoneutral zone, the comfortable range within which your core temperature can drift without your body reacting.

As oestrogen falls, that zone narrows sharply. Temperature changes your body used to absorb without comment now set off the whole cooling routine of flushing and sweating.

A group of nerve cells in the hypothalamus, known as KNDy neurons, plays a central part. The name comes from the three signalling molecules they produce, kisspeptin, neurokinin B and dynorphin. Researchers think neurokinin B is directly responsible for triggering the temperature response, and that understanding led to the development of fezolinetant, a newer non-hormonal treatment that targets this pathway.

What triggers hot flushes?

Several triggers come up again and again. Alcohol is among the most widely reported, with red wine and spirits often singled out, and you can read more in our guide to alcohol and menopause.

Caffeine, spicy food and hot drinks are common culprits, along with warm rooms, tight clothing around the neck and chest, and acute stress. Smoking is associated with more frequent and more severe flushes.

Keeping a note of when your flushes happen can help you spot which of these apply to you.

What treatments are available for hot flushes?

Several treatments have good evidence behind them, and the right choice depends on your health history and your preferences. It is a decision to talk through with your GP or a menopause specialist.

Hormone replacement therapy (HRT). HRT is the most effective treatment studied for vasomotor symptoms. A Cochrane review of placebo-controlled trials found it cut how often hot flushes happen by around 75%, and made them less severe. It is not suitable for everyone, and your doctor will look at whether any health factors rule it out for you. Our guide to what HRT is covers the benefits and risks in more detail.

Fezolinetant. Licensed in the UK in 2023 under the brand name Veoza, fezolinetant was the first non-hormonal treatment developed specifically for the vasomotor symptoms of menopause. It works on the neurokinin 3 receptor in the hypothalamus. In 2026 NICE recommended it on the NHS for moderate to severe hot flushes and night sweats when HRT isn't suitable or a woman would rather not take it. In clinical trials it produced meaningful, sustained reductions in how often hot flushes happened and how severe they felt.

SSRIs and SNRIs. These antidepressant medicines have modest evidence for reducing hot flushes, although the reductions seen are smaller than with HRT.

Cognitive behavioural therapy (CBT). CBT adapted for menopause leaves the number of flushes much the same and reduces how disruptive they feel. The evidence was strong enough for NICE to include it in its guidance. Our guide to CBT for menopause explains what it involves.

Everyday adjustments. Cooling the bedroom, wearing natural fibres and cutting back on alcohol and caffeine can reduce the frequency and severity of flushes enough to make a difference for some women.

You can find more on the options outside HRT in our guide to non-hormonal menopause treatments. Bringing a record of your symptoms, and a sense of how your own hormones are changing over time, can make that conversation with your GP more productive. The test explains how we help you build that picture of your own normal.

Questions women ask

How long does a hot flush last?

Each episode usually lasts two to four minutes, although experiences vary a great deal. A chill often follows as your body overcorrects after the wave of heat.

What causes hot flushes in menopause?

Falling oestrogen narrows the thermoneutral zone, the comfortable temperature range your brain's thermostat allows. Small changes in temperature that your body used to absorb now trigger flushing and sweating. Nerve cells in the hypothalamus that produce neurokinin B play a central part in setting off that response.

Is there a non-hormonal treatment for hot flushes?

Fezolinetant, sold as Veoza, was licensed in the UK in 2023 as the first non-hormonal treatment developed specifically for menopausal hot flushes. SSRIs and SNRIs have modest evidence, and CBT adapted for menopause can make flushes feel less disruptive. Your GP or menopause specialist can talk through which options might suit you.

References

  • Freedman RR. (2014). Menopausal hot flashes: mechanisms, endocrinology, treatment. Journal of Steroid Biochemistry and Molecular Biology, 142: 115–120.

  • NICE. (2019). Menopause: diagnosis and management. Guideline NG23.

  • Johnson KA, et al. (2023). Efficacy and safety of fezolinetant in moderate to severe vasomotor symptoms associated with menopause: a phase 3 RCT. Journal of Clinical Endocrinology and Metabolism, 108(8): 1981–1997.

  • NICE. (2026). Fezolinetant for treating vasomotor symptoms associated with the menopause. Technology appraisal guidance TA1143.

  • MacLennan AH, et al. (2004). Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database of Systematic Reviews, (4): CD002978.

Ready to know your normal?

Choose your test

Keep reading.